INS and type 2 diabetes mellitus: Although the alloxan model offers valuable insights into hyperglycemia and β‐cell‐related interventions, its ability to reflect the complex metabolic disturbances involved in Type 2 diabetes, including insulin resistance, systemic inflammation, and lipid metabolism disorders, is limited.